# LifeSprout

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lifesprout

- Industry: Biotechnology
- Headquarters: Baltimore, US
- Website: www.lifesproutbio.com
- Total disclosed funding: $35M
- Latest round: Series A (Apr 27, 2020)
- Investors on record: 10

## About

Founded in 2015 and based in Maryland, US, LifeSprout, Inc. is a biotechnology company that creates synthetic soft tissue substitutes for aesthetic and reconstructive medicine used by cancer and trauma patients. The company's Regenerative Matrix platform develops products that look and feel like the body's own tissues for patients with soft tissue losses from aging, cancer, metabolic disease, and orphan indications. It also offers Lumina, which is an aesthetic filler that enables immediate, natural restoration with biostimulatory effects.

## Funding rounds

- Series A, Apr 27, 2020, $29M — Redmile Group, Abell Foundation, Emerald Development Managers, Triskelion Capital, Catalio Capital Management, Nexus Management LP
- Seed, May 29, 2019, $6.5M — AngelMD, Kairos Ventures, Maryland Technology Development Corporation, Ginkgo Gofar Group, Triskelion Capital

## Investors

- AngelMD — Seed
- Kairos Ventures (https://capitalatlas.ai/funds/kairos-ventures) — Seed
- Maryland Technology Development Corporation — Seed
- Ginkgo Gofar Group — Seed
- Triskelion Capital — Seed, Series A
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series A
- Abell Foundation — Series A
- Emerald Development Managers (https://capitalatlas.ai/funds/emerald-development-managers) — Series A
- Catalio Capital Management (https://capitalatlas.ai/funds/catalio-capital-management) — Series A
- Nexus Management LP — Series A